Illumina Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Illumina Stock Summary

Illumina competes with Thermo Fisher, Danaher, Waters, IDEXX Laboratories, and Agilent Technologies. Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. The company was incorporated in 1998 and is based in San Diego, California. Illumina operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 9800 people.

Illumina Key Financial Ratios

Illumina Key Balance Sheet Accounts

Illumina Key Income Statement Accounts

Illumina Key Cash Accounts

Illumina Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Illumina's current stock value. Our valuation model uses many indicators to compare Illumina value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Illumina competition to find correlations between indicators driving Illumina's intrinsic value. More Info.Illumina is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Illumina's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Illumina's earnings, one of the primary drivers of an investment's value.

Illumina's Earnings Breakdown by Geography

Illumina Systematic Risk

Today, most investors in Illumina Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Illumina's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Illumina growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Illumina help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Illumina. We use our internally-developed statistical techniques to arrive at the intrinsic value of Illumina based on widely used predictive technical indicators. In general, we focus on analyzing Illumina Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Illumina's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Illumina. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.